Skip to main content
TipRanks
Go Ultimate75% OFF

Nanobiotix (0QAV) Ratios

4 Followers

Nanobiotix Ratios

GB:0QAV's free cash flow for Q2 2026 was €-22.66M. For the 2026 fiscal year, GB:0QAV's free cash flow was decreased by €-627.00K and operating cash flow was €-22.03M. See a summary of the company’s cash flow.

Financial ratios
RatiosDec 25Dec 24Dec 23Mar 23Dec 21
Liquidity Ratios
Current Ratio1.091.041.751.382.53
Quick Ratio1.091.041.751.382.53
Cash Ratio0.920.841.511.022.28
Solvency Ratio-0.15-0.50-0.40-0.64-0.61
Operating Cash Flow Ratio-0.58-0.33-0.25-1.00-0.84
Short-Term Operating Cash Flow Coverage-10.78-5.34-3.26-10.57-4.38
Net Current Asset Value€ -89.49M€ -71.66M€ -8.40M€ -34.46M€ 18.08M
Leverage Ratios
Debt-to-Assets Ratio1.410.760.540.890.45
Debt-to-Equity Ratio-1.13-0.77-27.44-1.971.72
Debt-to-Capital Ratio8.80-3.441.042.040.63
Long-Term Debt-to-Capital Ratio19.22-1.901.052.590.55
Financial Leverage Ratio-0.80-1.03-50.95-2.213.81
Debt Service Coverage Ratio-0.89-5.25-2.56-5.27-5.56
Interest Coverage Ratio-1.04-8.46-3.35-8.65-78.36
Debt to Market Cap0.100.330.190.380.16
Interest Debt Per Share2.231.251.591.691.34
Net Debt to EBITDA-3.53-0.020.82-0.270.83
Profitability Margins
Gross Profit Margin100.00%100.00%100.00%68.59%26470.00%
EBIT Margin-45.75%544.80%-105.12%-1157.56%-471650.00%
EBITDA Margin-40.71%530.83%-100.09%-1126.15%-456050.00%
Operating Profit Margin-36.49%589.13%-89.09%-1057.22%-525790.00%
Pretax Profit Margin-80.82%586.02%-131.68%-1279.77%-494890.00%
Net Profit Margin-80.83%586.89%-132.08%-1194.33%-470030.00%
Continuous Operations Profit Margin-80.83%586.89%-132.08%-1194.33%-470030.00%
Net Income Per EBT100.01%100.15%100.30%93.32%94.98%
EBT Per EBIT221.46%99.47%147.80%121.05%94.12%
Return on Assets (ROA)-35.36%-101.06%-42.28%-95.44%-46.23%
Return on Equity (ROE)28.36%103.70%2154.10%210.91%-176.09%
Return on Capital Employed (ROCE)-105.51%-806.22%-60.83%-231.27%-81.11%
Return on Invested Capital (ROIC)-74.29%-510.16%-54.60%-178.54%-68.38%
Return on Tangible Assets-35.37%-101.07%-42.28%-95.44%-46.23%
Earnings Yield-2.59%-47.73%-16.27%-45.21%-18.51%
Efficiency Ratios
Receivables Turnover3.86-1.363.171.680.00
Payables Turnover0.000.000.000.38-0.53
Inventory Turnover0.000.000.000.000.00
Fixed Asset Turnover6.49-2.104.810.670.00
Asset Turnover0.44-0.170.320.080.00
Working Capital Turnover Ratio7.63-0.581.160.140.00
Cash Conversion Cycle94.57-268.35115.30-755.89142421.02
Days of Sales Outstanding94.57-268.35115.30217.20141729.50
Days of Inventory Outstanding0.000.000.000.000.00
Days of Payables Outstanding0.000.000.00973.09-691.52
Operating Cycle94.57-268.35115.30217.20141729.50
Cash Flow Ratios
Operating Cash Flow Per Share-0.70-0.41-0.34-1.09-0.89
Free Cash Flow Per Share-0.72-0.43-0.35-1.09-0.90
Dividend Paid and CapEx Coverage Ratio-61.21-23.11-38.04-408.81-133.06
Capital Expenditure Coverage Ratio-61.21-23.11-38.04-408.81-133.06
Operating Cash Flow Coverage Ratio-0.35-0.38-0.25-0.72-0.67
Operating Cash Flow to Sales Ratio-1.131.68-0.42-7.96-3100.40
Free Cash Flow Yield-3.67%-14.29%-5.25%-30.21%-12.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-38.24-2.10-6.15-2.21-5.40
Price-to-Sales (P/S) Ratio31.19-12.308.1226.4225390.13
Price-to-Book (P/B) Ratio-10.94-2.17-132.44-4.669.51
Price-to-Free Cash Flow (P/FCF) Ratio-27.22-7.00-19.05-3.31-8.13
Price-to-Operating Cash Flow Ratio-27.67-7.30-19.56-3.32-8.19
Price-to-Earnings Growth (PEG) Ratio0.59-0.060.18-0.102.48
Enterprise Value Multiple-80.15-2.34-7.29-2.62-4.74
Enterprise Value967.22M143.91M219.36M140.76M216.00M
EV to EBITDA-80.15-2.34-7.29-2.62-4.74
EV to Sales32.63-12.407.3029.4721600.03
EV to Free Cash Flow-28.47-7.05-17.12-3.69-6.91
EV to Operating Cash Flow-28.94-7.36-17.58-3.70-6.97
Tangible Book Value Per Share-1.78-1.39-0.05-0.780.77
Shareholders’ Equity Per Share-1.78-1.39-0.05-0.780.77
Tax and Other Ratios
Effective Tax Rate-0.00-0.00-0.000.070.05
Revenue Per Share0.63-0.250.820.140.00
Net Income Per Share-0.51-1.44-1.08-1.64-1.35
Tax Burden1.001.001.000.930.95
Interest Burden1.771.081.251.111.05
Research & Development to Revenue0.78-3.491.286.592923.40
SG&A to Revenue0.68-1.730.720.001901.70
Stock-Based Compensation to Revenue0.12-0.370.110.66320.10
Income Quality1.390.290.310.670.66

Currency in EUR